VNDA peer analysis
Vanda Pharmaceuticals (VNDA) against its competitors: price, today's move, 1-year return and market value side by side.
- VNDA's peers: ACHV (Achieve Life Sciences), ALLO (Allogene Therapeutics), ARCT (Arcturus), AVIR (Atea Pharmaceuticals), CAPR (Capricor), HUMA (Humacyte), IMRX (Immuneering), SGMT (Sagimet Biosciences).
VNDA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACHV Achieve Life Sciences | $6.78 | 0.89% | 47.71% | $697.68M |
| ALLO Allogene Therapeutics | $0.63 | -4.83% | -49.63% | $219.90M |
| ARCT Arcturus | $7.55 | -0.66% | 25.00% | $217.61M |
| AVIR Atea Pharmaceuticals | $3.97 | 1.02% | 26.03% | $318.81M |
| CAPR Capricor | $1.65 | -78.15% | -70.83% | $95.27M |
| HUMA Humacyte | $0.46 | -14.97% | -60.57% | $128.15M |
| IMRX Immuneering | $3.33 | -3.48% | -53.56% | $215.66M |
| SGMT Sagimet Biosciences | $9.07 | -5.72% | 15.54% | $647.31M |
| TRDA Entrada Therapeutics | $4.20 | -9.48% | -51.89% | $164.43M |
| VYGR Voyager Therapeutics | $1.53 | -4.97% | -63.22% | $95.21M |
| VNDA Vanda Pharmaceuticals | $3.46 | -5.72% | -32.68% | $209.23M |